Who makes BC2027 for Injection?

BC2027 for Injection is developed by Biocity Biopharmaceutics Co., Ltd..

What development phase is BC2027 for Injection in?

BC2027 for Injection is in Phase 1.

Last reviewed 2026-04-19 · How we verify

Biocity Biopharmaceutics Co., Ltd. · Phase 1 active Small molecule

Generic name	BC2027 for Injection
Sponsor	Biocity Biopharmaceutics Co., Ltd.
Modality	Small molecule
Phase	Phase 1

No approved indications tracked.

No common side effects on file.